Oxidative stress regulatory pathway

The oxidative stress regulatory pathways in erythrocytes represent a vital defense system consisting of enzymatic and non-enzymatic components that maintain redox balance in red blood cells (NIH, 2022). Because erythrocytes lack a nucleus and mitochondria, they rely heavily on the pentose phosphate pathway to generate NADPH, which serves as the essential reducing equivalent for antioxidant enzymes (ClinPGX, 2024). Key enzymes in this network include glucose-6-phosphate dehydrogenase (G6PD), superoxide dismutase (SOD), catalase, and the glutathione-dependent enzymes glutathione peroxidase and glutathione reductase (MDPI, 2023). These pathways function to neutralize reactive oxygen species (ROS) and prevent the oxidation of hemoglobin to methemoglobin, thereby preserving the cell's structural integrity and oxygen-carrying capacity (ACS, 2022). Dysregulation or genetic deficiencies in these pathways, such as G6PD deficiency, lead to increased susceptibility to oxidative damage and hemolytic anemia (PubMed, 2019). Various drugs, including antimalarials like primaquine and urate oxidases like rasburicase, can trigger oxidative crises by overwhelming these regulatory mechanisms (ClinPGX, 2024). Conversely, therapeutic agents like methylene blue or N-acetylcysteine can be used to support or restore redox homeostasis in clinical settings (Frontiers, 2023). Understanding these pathways is crucial for managing drug-induced toxicities and treating hereditary hematologic disorders.

Other names

Erythrocyte antioxidant defense systemRBC oxidative stress pathwayPentose phosphate pathway (redox component)Glutathione metabolism pathway

Modulation of NADPH production via the pentose phosphate pathway, enzymatic neutralization of reactive oxygen species (ROS), and maintenance of reduced glutathione (GSH) levels to prevent oxidative damage to hemoglobin and the erythrocyte membrane.